Mutation analysis of p53 in ovarian tumors by DHPLC

Journal of Biochemical and Biophysical Methods

Volumn 47, Issue 1-2, 2001, Pages 73-81

  Gross, E ^a   Kiechle, M ^a   Arnold, N ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

DHPLC analysis; Mutation detection; Ovarian carcinoma; p53

Indexed keywords

PROTEIN P53;

CANCER CELL; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; HETEROZYGOSITY LOSS; HETEROZYGOTE DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRON; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; NUCLEIC ACID DENATURATION; OVARIAN NEOPLASMS;

EID: 0035969968     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(00)00153-6     Document Type: Conference Paper

References (35)

1. Mutations in the p53 gene occur in diverse human tumour types
2. p53, the cellular gatekeeper for growth and division
3. Database of p53 gene somatic mutations in human tumors and cell lines
4. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
5. p53: Puzzle and paradigm
6. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
7. Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors
8. TP53 mutation in ovarian carcinoma
9. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers
10. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations
11. Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions
12. Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors
13. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation
14. Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos
15. The p53 tumor suppressor gene in breast cancer
16. A prospective trial of midwest breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome
17. The tumor suppressor genes
18. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
19. The aberrant p53 protein
20. p53 in tumour pathology: Can we trust immunohistochemistry? - Revisited!
21. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
22. Correlation of TP53 mutations and p53 expression in ovarian tumors
23. A polymorphism in intron 2 of the TP53 gene
24. Current methods of mutation detection
25. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene
26. Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC)
27. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC)
28. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection
29. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations
30. A fast, cheap and highly sensitive technique for mutation analysis in hereditary breast and ovarian cancer
31. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC
32. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations
33. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis